In our study, we not only illustrated high HOXB-AS3 expression as a poor prognostic biomarker in AML and MDS, but also disclosed its promotion effect on cell proliferation in two myeloid cell lines (Fig. 2). The gene discussed is PDS5B; the disease is myelodysplastic syndrome.